Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiersten

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Breast (Edinburgh, Scotland)|August 25, 2004
Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancerAmy Tiersten, Jennifer Wo, Caron Jacobson, et al.
Oncology|August 20, 2023
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian CancerChrystal A Landry, Julia Blanter, Meng Ru, et al.
Clinical Breast Cancer|January 21, 2025
Low Dose Tamoxifen for Breast Cancer Prevention: A Real-World ExperienceRima Patel, Cao Jin, Diana Jaber, et al.
Gynecologic Oncology|December 14, 2004
Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literatureKatherine D Crew, Michael H Cohen, Daniel H Smith, et al.
Journal of the National Cancer Institute|October 16, 2003
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancerDawn Hershman, Mitchell Weinberg, Zachary Rosner, et al.
Seminars in Oncology|December 3, 2014
A case of vasculitis in a breast cancer patient treated with T-DM1Aarti S Bhardwaj, Beth McLellan, Maria R Robinson, et al.
Oncology|February 5, 2010
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group StudyAmy D Tiersten, James Moon, Harriet O Smith, et al.
Cannabis and Cannabinoid Research|July 4, 2025
Oral Cannabis for Taxane-Induced Neuropathy: A Pilot Randomized Placebo-Controlled StudyMargaret Haney, Tse-Hwei Choo, Amy Tiersten, et al.
Anticancer Research|October 15, 2010
Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancerTamar Safra, Eleni Andreopoulou, Benjamin Levinson, et al.
Gynecologic Oncology|January 14, 2009
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Amy D Tiersten, P Y Liu, Harriet O Smith, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Breast (Edinburgh, Scotland)|August 25, 2004
Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancerAmy Tiersten, Jennifer Wo, Caron Jacobson, et al.
Oncology|August 20, 2023
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian CancerChrystal A Landry, Julia Blanter, Meng Ru, et al.
Clinical Breast Cancer|January 21, 2025
Low Dose Tamoxifen for Breast Cancer Prevention: A Real-World ExperienceRima Patel, Cao Jin, Diana Jaber, et al.
Gynecologic Oncology|December 14, 2004
Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literatureKatherine D Crew, Michael H Cohen, Daniel H Smith, et al.
Journal of the National Cancer Institute|October 16, 2003
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancerDawn Hershman, Mitchell Weinberg, Zachary Rosner, et al.
Seminars in Oncology|December 3, 2014
A case of vasculitis in a breast cancer patient treated with T-DM1Aarti S Bhardwaj, Beth McLellan, Maria R Robinson, et al.
Oncology|February 5, 2010
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group StudyAmy D Tiersten, James Moon, Harriet O Smith, et al.
Cannabis and Cannabinoid Research|July 4, 2025
Oral Cannabis for Taxane-Induced Neuropathy: A Pilot Randomized Placebo-Controlled StudyMargaret Haney, Tse-Hwei Choo, Amy Tiersten, et al.
Anticancer Research|October 15, 2010
Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancerTamar Safra, Eleni Andreopoulou, Benjamin Levinson, et al.
Gynecologic Oncology|January 14, 2009
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Amy D Tiersten, P Y Liu, Harriet O Smith, et al.
Pageof 9